The Committee of the Parties of the Council of Europe's MEDICRIME Convention granted observer status to the Brazzaville Foundation at the end of the first day of its fourth plenary meeting on 26 May 2021 in Strasbourg.
The Foundation will therefore be able to attend the Committee's meetings from the second day of its plenary meeting on 27 May.
The MEDICRIME Convention is a legally binding instrument in the field of criminal law. It criminalises the counterfeiting, manufacturing and distribution of medical products placed on the market without authorisation, or in violation of safety standards. This convention is part of the legal arsenal that the signatory countries of the Lomé Initiative have committed to ratify.
Richard Amalvy, Chief Executive, who presented the application of the Brazzaville Foundation this morning, said: "We would like to thank the Committee of the Parties of the MEDICRIME Convention and the Executive Secretariat for the trust placed in our foundation and in the signatories of the Lomé Initiative, which we are accompanying in signing and ratifying the Convention. As I said this morning in plenary, we want to strengthen the alliances that enable us to combat the trafficking of fake medicines in Africa. This new status gives us the opportunity to do so.”
On 2 December 2020, Professor M. Mijiyawa, Minister of Health of the Republic of Togo, and Richard Amalvy, participated in the 3rd plenary meeting to exchange views on the systemic and inter-ministerial approach to falsified and substandard medicines and the follow-up of the Lomé Initiative. To find out more, read the article here.